I feel the same way. Been in this for about 3 years minimum. The science is what I stay in for, NOT the CEO. My feeling is that "our" man Rabin is here for, and his job is, to solicit financing for this company for these trials. Thus his numerous song and dance performances at investors conferences. Does he have knowledge of the science? Probably not. But thats what Lanza is all about. Without Lanza there is no ACTC. It is his brain that will decide the future of ACTC, not Rabin. If due to Lanza's life long work, these trials are successful, this will be a home run. All the talk of eventual buyout or partnerships will just be additional euphoria. The SCIENCE is what this investment is all about, and if successful Rabin has done his job keeping this company afloat til then. Afterwards if (and thats a big "if) this company is to go it alone, a REAL CEO who has experience running a major business is needed. Does the CEO sale of stock bother me? Hell yes, and that is why I am reluctant to buy more and why the price is buried at the lows. But to leave now and miss out on one of the greatest historical medical achievements and breakthoughs would be disheartening to say the least.